Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Merighi

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Cells|April 30, 2020
Adenosinergic System Involvement in Ischemic Stroke Patients' LymphocytesSilvia Pasquini, Fabrizio Vincenzi, Ilaria Casetta, et al.
Pharmacological Reviews|November 13, 2014
The A3 adenosine receptor: history and perspectivesPier Andrea Borea, Katia Varani, Fabrizio Vincenzi, et al.
International Journal of Molecular Sciences|May 14, 2022
A<sub>2A</sub> Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity?Stefania Merighi, Manuela Nigro, Alessia Travagli, et al.
Biochemical Pharmacology|February 14, 2002
Binding thermodynamics at the human A(3) adenosine receptorStefania Merighi, Katia Varani, Stefania Gessi, et al.
British Journal of Pharmacology|April 27, 2002
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophilsKatia Varani, Stefania Gessi, Stefania Merighi, et al.
Purinergic Signalling|April 12, 2008
Novel selective antagonist radioligands for the pharmacological study of A(2B) adenosine receptorsStefania Gessi, Katia Varani, Stefania Merighi, et al.
Biochemical Pharmacology|November 6, 2003
Alteration of A(3) adenosine receptors in human neutrophils and low frequency electromagnetic fieldsKatia Varani, Stefania Gessi, Stefania Merighi, et al.
Molecular Pharmacology|January 26, 2002
A(3) adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical studyStefania Gessi, Katia Varani, Stefania Merighi, et al.
Cells|September 28, 2021
A<sub>2A</sub> Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's DiseaseStefania Gessi, Tino Emanuele Poloni, Giulia Negro, et al.
Frontiers in Pharmacology|April 8, 2021
An Open Question: Is the A<sub>2A</sub> Adenosine Receptor a Novel Target for Alzheimer's Disease Treatment?Stefania Merighi, Tino Emanuele Poloni, Lucia Pelloni, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Cells|April 30, 2020
Adenosinergic System Involvement in Ischemic Stroke Patients' LymphocytesSilvia Pasquini, Fabrizio Vincenzi, Ilaria Casetta, et al.
Pharmacological Reviews|November 13, 2014
The A3 adenosine receptor: history and perspectivesPier Andrea Borea, Katia Varani, Fabrizio Vincenzi, et al.
International Journal of Molecular Sciences|May 14, 2022
A<sub>2A</sub> Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity?Stefania Merighi, Manuela Nigro, Alessia Travagli, et al.
Biochemical Pharmacology|February 14, 2002
Binding thermodynamics at the human A(3) adenosine receptorStefania Merighi, Katia Varani, Stefania Gessi, et al.
British Journal of Pharmacology|April 27, 2002
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophilsKatia Varani, Stefania Gessi, Stefania Merighi, et al.
Purinergic Signalling|April 12, 2008
Novel selective antagonist radioligands for the pharmacological study of A(2B) adenosine receptorsStefania Gessi, Katia Varani, Stefania Merighi, et al.
Biochemical Pharmacology|November 6, 2003
Alteration of A(3) adenosine receptors in human neutrophils and low frequency electromagnetic fieldsKatia Varani, Stefania Gessi, Stefania Merighi, et al.
Molecular Pharmacology|January 26, 2002
A(3) adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical studyStefania Gessi, Katia Varani, Stefania Merighi, et al.
Cells|September 28, 2021
A<sub>2A</sub> Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's DiseaseStefania Gessi, Tino Emanuele Poloni, Giulia Negro, et al.
Frontiers in Pharmacology|April 8, 2021
An Open Question: Is the A<sub>2A</sub> Adenosine Receptor a Novel Target for Alzheimer's Disease Treatment?Stefania Merighi, Tino Emanuele Poloni, Lucia Pelloni, et al.
Pageof 11